Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIG5: FEC vs EP in Early Breast Cancer
NCT02450058Phase 3Completed
- Start
- Nov 1996
- Primary completion
- May 2012
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection in breast cancer. Started Nov 1996; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02450058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02450058.